What's Happening With Pasithea Therapeutics Stock Today?
What's Happening With Pasithea Therapeutics Stock Today?
Pasithea Therapeutics Corp (NASDAQ:KTTA) shares are trading higher after the company confirmed that an independent special committee of its Board of Directors thoroughly reviewed and rejected an unsolicited, non-binding acquisition proposal from Lucy Scientific Discovery Inc (NASDAQ:LSDI).
Pasithea Therapeutics 納斯達克股票代碼：KTTA）證實其董事會獨立特別委員會徹底審查並拒絕了主動提出的、不具約束力的收購提議，此後，該公司股價走高 露西科學探索公司 （納斯達克股票代碼：LSDI）。
Under the terms of the offer made on June 5, Lucy proposed to pay $0.60 in cash and 0.25 cents in Lucy stock for every share of Pasithea common stock.
根據6月5日提出的要約條款，露西提議爲每股Pasithea普通股支付0.60美元的現金和0.25美分的露西股票。
Since Pasithea's stock closed at $0.35 per share on June 1, 2023, the Proposal of $0.85 per share equates to a 142% premium to Pasithea's share price. The cash component alone represents a 71% premium.
自Pasithea的股票於2023年6月1日收於每股0.35美元以來，每股0.85美元的提案相當於Pasithea的股價高出142％。僅現金部分就佔71％的溢價。
The Special Committee determined that the Lucy proposal does not reflect Pasithea's strategic value and prospects for continued growth and is not in the company's or its stockholders' best interests.
特別委員會認定，露西的提案沒有反映Pasithea的戰略價值和持續增長的前景，也不符合公司或其股東的最大利益。
Concurrently, Pasithea's Board authorized the repurchase, through a $4.0 million tender offer, of up to approximately 5.7 million shares of the company's outstanding common stock, at an anticipated cash purchase price of $0.70 per share.
同時，Pasithea董事會授權通過400萬美元的要約回購該公司多達約570萬股已發行普通股，預計現金購買價格爲每股0.70美元。
Price Action: KTTA shares are up 23.9% at $0.58 on the last check Thursday.
價格走勢： 週四最後一次支票顯示，KTTA股價上漲23.9％，至0.58美元。
譯文內容由第三人軟體翻譯。